Striant is a brand name of testosterone, approved by the FDA in the following formulation(s):
STRIANT (testosterone - tablet, extended release; buccal)
Manufacturer: ACTIENT PHARMS
Approval date: June 19, 2003
Strength(s): 30MG [RLD]
Has a generic version of Striant been approved?
No. There is currently no therapeutically equivalent version of Striant available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Striant. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Bioadhesive progressive hydration tablets and methods of making and using the same
Patent 6,248,358
Issued: June 19, 2001
Inventor(s): Bologna; William J. & Levine; Howard L. & Cartier; Philippe & de Ziegler; Dominique
Assignee(s): Columbia Laboratories, Inc.
A bioadhesive tablet wherein the active ingredient may be protected from water or the surrounding environment, thereby protecting it from metabolism or from other degradation caused by moisture, enzymes, or pH effects, and making it bioavailable only at a controlled rate. The active ingredient may be protected from moisture during the manufacturing process and more importantly may be protected from moisture and the immediate septic environment until after the patient has applied the tablet, and then only at a slow and controlled rate. It is by this process of progressive hydration that the active ingredient remains protected for many hours after administration. It is also by the process of progressive hydration that controlled and sustained release is achieved because only that part of the active ingredient that is the hydrated (aqueous) fraction of the tablet is available for absorption (bioavailable).
Patent expiration dates:
See also...
- Striant Consumer Information (Drugs.com)
- Striant Consumer Information (Wolters Kluwer)
- Striant Consumer Information (Cerner Multum)
- Striant Advanced Consumer Information (Micromedex)
- Testosterone Consumer Information (Drugs.com)
- Testosterone Consumer Information (Wolters Kluwer)
- Testosterone Gel Consumer Information (Wolters Kluwer)
- Testosterone Patch Consumer Information (Wolters Kluwer)
- Testosterone Solution Consumer Information (Wolters Kluwer)
- Testosterone buccal system Consumer Information (Cerner Multum)
- Testosterone injection Consumer Information (Cerner Multum)
- Testosterone topical Consumer Information (Cerner Multum)
- Androplex Advanced Consumer Information (Micromedex)
- Testosterone Buccal Advanced Consumer Information (Micromedex)
- Testosterone Topical application Advanced Consumer Information (Micromedex)
- Testosterone Transdermal Advanced Consumer Information (Micromedex)
- Testosterone AHFS DI Monographs (ASHP)